Literature DB >> 12170092

'Spindle cell oncocytoma' of the adenohypophysis: a tumor of folliculostellate cells?

Federico Roncaroli1, Bernd W Scheithauer, Giovanna Cenacchi, Eva Horvath, Kalman Kovacs, Ricardo V Lloyd, Patrice Abell-Aleff, Mariarita Santi, Allan J Yates.   

Abstract

We describe five primary tumors of the adenohypophysis featuring mitochondrion-rich spindle cells. The patient ages ranged from 53 to 71 years (mean 61.6 years); two were female. All presented with panhypopituitarism. Two also had visual field defect. On neuroimaging all tumors showed suprasellar extension and were indistinguishable from pituitary adenoma. None showed imaging or operative evidence of dural involvement. All were gross totally removed: four by transsphenoidal surgery and one by frontal craniotomy. Follow-up ranged from 2 to 68 months (mean 35.4 months). No recurrences were noted. The clinical workup was noncontributory in all but two patients: one (case no. 4) with an oncocytic thyroid adenoma and another (case no. 5) with squamous carcinoma of both the uterine cervix and of vocal cord. Histologically, the five tumors were composed mainly of fascicles of spindle cells with eosinophilic, granular cytoplasm. Mitoses were rare and necrosis was absent. Neoplastic cells were immunoreactive for vimentin, epithelial membrane antigen, S-100 protein, and galectin-3. Stains for pituitary hormones, synaptophysin, chromogranin, glial fibrillary acidic protein, cytokeratin CAM5.2, smooth muscle actin, CD34, and CD68 were negative. No thyroglobulin immunoreactivity was noted in the tumor of case no. 4. Ultrastructurally, the neoplastic cells contained numerous mitochondria with lamellar cristae. The neoplastic cells were linked by intermediate junctions and desmosomes. No secretory granules were noted. The histologic, immunohistochemical, and fine structural features of these tumors were unlike those of pituitary adenoma or any other primary sellar tumor. A derivation from adenohypophyseal folliculostellate cells is suggested.

Entities:  

Mesh:

Year:  2002        PMID: 12170092     DOI: 10.1097/00000478-200208000-00010

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  36 in total

1.  Pituicytoma: characterization of a unique neoplasm by histology, immunohistochemistry, ultrastructure, and array-based comparative genomic hybridization.

Authors:  Joanna J Phillips; Anjan Misra; Burt G Feuerstein; Sandeep Kunwar; Tarik Tihan
Journal:  Arch Pathol Lab Med       Date:  2010-07       Impact factor: 5.534

Review 2.  Recurrent spindle cell oncocytoma of the pituitary, a case report and review of literature.

Authors:  Yared N Demssie; Jacob Joseph; Timothy Dawson; Gareth Roberts; John de Carpentier; Simon Howell
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

3.  TTF-1 expressing sellar neoplasm with ependymal rosettes and oncocytic change: mixed ependymal and oncocytic variant pituicytoma.

Authors:  Zaid Saeed Kamil; Grant Sinson; Hasan Gucer; Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2014-12       Impact factor: 3.943

4.  [The 2017 WHO classification of pituitary tumors].

Authors:  Wolfgang Saeger
Journal:  Pathologe       Date:  2021-04-20       Impact factor: 1.011

5.  Freiburg Neuropathology Case Conference : A Pituitary Mass Lesion.

Authors:  C A Taschner; R Sankowski; J M Shah; H Urbach; R Hartmann; M Prinz
Journal:  Clin Neuroradiol       Date:  2016-12       Impact factor: 3.649

Review 6.  Spindle cell oncocytoma of the pituitary gland.

Authors:  Alexandra M Giantini Larsen; David J Cote; Hasan A Zaidi; Wenya Linda Bi; Paul J Schmitt; J Bryan Iorgulescu; Michael B Miller; Timothy R Smith; M Beatriz Lopes; John A Jane; Edward R Laws
Journal:  J Neurosurg       Date:  2018-10-19       Impact factor: 5.115

Review 7.  Pituitary stem cells: candidates and implications.

Authors:  Farshad Nassiri; Michael Cusimano; Jeff A Zuccato; Safraz Mohammed; Fabio Rotondo; Eva Horvath; Luis V Syro; Kalman Kovacs; Ricardo V Lloyd
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

8.  Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.

Authors:  Paweena Chunharojrith; Yuki Nakayama; Xiaobing Jiang; Rachel E Kery; Jun Ma; Cristine S De La Hoz Ulloa; Xun Zhang; Yunli Zhou; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2015-08-15       Impact factor: 4.102

9.  Signaling pathway networks mined from human pituitary adenoma proteomics data.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  BMC Med Genomics       Date:  2010-04-28       Impact factor: 3.063

10.  Fibroblast growth factor-2 autofeedback regulation in pituitary folliculostellate TtT/GF cells.

Authors:  George Vlotides; Yen-Hao Chen; Tamar Eigler; Song-Guang Ren; Shlomo Melmed
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.